Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 12/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29121251 | 1.00 | FFAR4 (0.43) | FFAR4FFAR1PARP10HCRTR1HCRTR2 | |
| SCHEMBL29121333 | 0.92 | FFAR4 (0.41) | FFAR4FFAR1ALDH1A1HPGD | |
| SCHEMBL28828399 | 0.92 | FFAR4 (0.39) | FFAR4FFAR1 | |
| SCHEMBL29121169 | 0.92 | FFAR4 (0.39) | FFAR4FFAR1 | |
| SCHEMBL28828514 | 0.92 | FFAR4 (0.41) | FFAR4FFAR1ALDH1A1HPGD | |
| SCHEMBL29121370 | 0.90 | FFAR4 (0.42) | FFAR4FFAR1PARP10HCRTR1HCRTR2 | |
| SCHEMBL28828364 | 0.89 | FFAR4 (0.38) | FFAR4ALDH1A1GAAMAPTTP53 | |
| SCHEMBL28828664 | 0.89 | PTGS2 (0.45) | FFAR4FFAR1GAAMAPTPTGS2 | |
| SCHEMBL29121276 | 0.89 | FFAR4 (0.38) | FFAR4ALDH1A1GAAMAPTTP53 | |
| SCHEMBL29121291 | 0.89 | PARP10 (0.36) | FFAR4FFAR1PARP10HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114829361-B | Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the same | 柳韩洋行 | 2024-07-16 | — | — | CN | claimed |
| CN-114829361-A | Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing same | 柳韩洋行 | 2022-07-29 | — | — | CN | claimed |
| CN-114829361-B | Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the same | 柳韩洋行 | 2024-07-16 | — | — | CN | disclosed |
| CN-114829361-A | Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing same | 柳韩洋行 | 2022-07-29 | — | — | CN | disclosed |